Evogene(EVGN)
$0.40+0.02 (+6.18%)
EVGN
Evogene financials statements
$0.40
At close:+0.02 (+6.18%)
Want to see EVGN full AI Analyst Report?
Evogene (EVGN) Income Statement
652 Followers
Evogene Income Statement
Last quarter (Q2 2026), Evogene's total revenue was $347.00K, a decrease of 60.75% from the same quarter last year. In Q2, Evogene's net income was $-1.77M. See Evogene’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.85M | $ 5.58M | $ 2.98M | $ 1.68M | $ 930.00K | |
| $ -241.00K | $ 3.20M | $ 1.49M | $ 766.00K | $ 163.00K | |
| $ 13.79M | $ 22.00M | $ 23.72M | $ 27.71M | $ 31.12M | |
| Depreciation and Amortization | $ 1.14M | $ 1.38M | $ 1.30M | $ 2.58M | $ 2.23M |
| $ -12.20M | $ -13.36M | $ -20.53M | $ -27.01M | $ -27.88M | |
| $ -14.03M | $ -18.80M | $ -22.23M | $ -26.94M | $ -30.95M | |
| $ 536.00K | $ 4.00M | $ 285.00K | $ -2.81M | $ 521.00K | |
| $ -13.50M | $ -14.81M | $ -21.95M | $ -29.75M | $ -30.43M | |
| $ -8.48M | $ -16.48M | $ -23.88M | $ -26.64M | $ -27.79M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.08 | $ -2.89 | $ -5.23 | $ -6.46 | $ -0.68 |
| Diluted EPS | $ -1.08 | $ -2.89 | $ -5.23 | $ -6.46 | $ -0.68 |
| Weighted Average Shares Outstanding | 7.87M | 5.70M | 4.57M | 4.12M | 41.01M |
| Weighted Average Shares Outstanding (Diluted) | 7.87M | 5.70M | 4.57M | 4.12M | 41.01M |
Currency in USD
